Sabrina Meo

Validation of Blood Collection Procedures for the Determination of Circulating Vascular Endothelial Growth Factor (VEGF) in Different Blood Compartments

Ruggero Dittadi, Sabrina Meo, F. Fabris et al. · The International Journal of Biological Markers · 2001 · 82 citations · Full text

Medicine, Hematology, Clinical Pharmacology +14

The Combination of the Selective Cyclooxygenase-2 Inhibitor Celecoxib with Weekly Paclitaxel Is a Safe and Active Second-Line Therapy for Non-Small Cell Lung Cancer

Giampietro Gasparini, Sabrina Meo, Giuseppe Cornelia et al. · The Cancer Journal · 2005 · 34 citations

Medicine, Oncology, Pharmacology +15

Quantitative measurement of soluble cytokeratin fragments in tissue cytosol of 599 node negative breast cancer patients: a prognostic marker possibly associated with apoptosis

Massimo Gion, Patrizia Boracchi, Ruggero Dittadi et al. · Breast Cancer Research and Treatment · 2000 · 19 citations

Medicine, Cell Biology, Oncology +15

The prognostic value of vascular endothelial growth factor, urokinase plasminogen activator and plasminogen activator inhibitor-1 in node-negative breast cancer

Sabrina Meo, Ruggero Dittadi, L. Peloso et al. · The International Journal of Biological Markers · 2004 · 16 citations

Medicine, Cancer Biology, Oncology +16

Serum CA549 in primary breast cancer: comparison with CA15.3 and MCA

Massimo Gion, Mario Plebani, R. Mione et al. · British Journal of Cancer · 1994 · 14 citations · Full text

Medicine, Oncology, Pathology +12